[ Price : $8.95]
Viking Therapeutics reports mixed data from a Phase 2 study for its oral obesity drug VK2735, with patients losing up to 12.2% of ...[ Price : $8.95]
FDA publishes a guidance with recommendations on the information to be in a predetermined change control plan in a marketing submi...[ Price : $8.95]
FDA denies a Ferring Pharmaceuticals petition asking the agency to reconsider its earlier denial of a petition seeking restriction...[ Price : $8.95]
An FDA guidance asks manufacturers and applicants of drug products packed in infusion bags to collect and report data on nitrosami...[ Price : $8.95]
FDA clears a NeuroOne Medical Technologies 510(k) to market its OneRF Trigeminal Nerve Ablation System for use in procedures to cr...[ Price : $8.95]
FDA warns Lenoir City, TN-based Les Encres LLC about QS and MDR violations in its illegal work as a specification developer for ad...[ Price : $8.95]
FDA grants Altimmune a fast track designation for pemvidutide and its use for treating alcohol use disorder.[ Price : $8.95]
FDA posts a new draft guidance entitled Oncology Therapeutic Radiopharmaceuticals (RPTs): Dosage Optimization During Clinical Deve...